Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 7Lymphoma 7Lymphoma, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Hairy Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Hematologic Diseases 2Sezary Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Cytokine Release Syndrome 1Burkitt Lymphoma 1

Interventions

pevonedistat 1ibrutinib 1fludarabine phosphate 1Pharmacogenomic Variants 1Etoposide 1Cyclophosphamide 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Prolymphocytic, B-Cell × Bendamustine Hydrochloride × Clear all
NCT02153580 2025-10-06

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
37 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Hairy Cell, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡